Treatment for Alopecia Areata in Adolescents

Initial Assessment and Treatment Approach

The British Journal of Dermatology recommends determining the extent and pattern of hair loss to guide treatment selection, as this is the primary factor determining therapeutic approach 3, 4
The British Journal of Dermatology suggests providing thorough counseling about the nature of alopecia areata, including its autoimmune basis, unpredictable course, and the fact that no treatment alters the long-term disease trajectory 5, 3
Assessing psychological impact is crucial, as adolescents with alopecia areata often experience significant quality of life impairment that may require psychological support or referral 3

The British Journal of Dermatology recommends intralesional triamcinolone acetonide injections as the first-line treatment for limited patchy disease, with a response rate of 62% 1, 2
The treatment involves injecting 0.05-0.1 mL of triamcinolone acetonide 5-10 mg/mL just beneath the dermis in the upper subcutis, with monthly injections 1, 2
The expected response duration is approximately 9 months if successful, with the main limitation being patient discomfort 1, 2

The British Journal of Dermatology recommends contact immunotherapy with DPCP as the best-documented treatment for extensive disease, with an expected response rate of 50-60% overall 1, 6, 8, 9
The treatment involves initial sensitization with 2% DPCP solution, followed by weekly applications starting at 0.001% concentration, increasing until mild dermatitis is achieved 1, 6, 9
The treatment duration may need to extend beyond 6 months, with one study showing response increasing from 30% at 6 months to 78% at 32 months 9

The British Journal of Dermatology recommends avoiding systemic corticosteroids due to inadequate evidence of efficacy and potentially serious side effects 5, 3
The British Journal of Dermatology suggests using caution with PUVA therapy due to high relapse rates and potential for unacceptably high cumulative UVA doses 1, 7, 10

The British Journal of Dermatology notes that intralesional corticosteroids are often poorly tolerated in children and adolescents due to discomfort 10
The British Journal of Dermatology emphasizes the importance of psychological support, as adolescents may experience significant behavioral changes, social withdrawal, and academic difficulties requiring referral to clinical or educational psychologists 3